Adding insulin to metformin may increase risk for nonfatal CV events, all-cause mortality versus adding a sulfonylurea
Adding insulin to metformin as second-line therapy may increase risk for nonfatal cardiovascular events and all-cause mortality compared with adding a sulfonylurea, according to a recent study.
Women with diabetes have a more than 40% higher risk of incident coronary heart disease than men, a new meta-analysis found.
HbA1c levels appear to increase as patients age, independent of glucose levels and insulin resistance, according to a new study.
This month's quiz asks readers to evaluate a 58-year-old man with type 2 diabetes mellitus, hypertension, and hyperlipidemia as a new patient.
Ten studies from 2013 with potential to change endocrinology practice were summarized in Annals of Internal Medicine's annual Update in Endocrinology, published in the June 3 issue.
The American Association of Clinical Endocrinologists and the American College of Endocrinology offered guidance on optimal and safe use of insulin pumps in a recent consensus statement.
Patients taking higher-potency statins for secondary prevention are more likely to develop diabetes than those on lower-potency statins, a recent study found.
More than 29 million people in the U.S., 9.3% of the population, have diabetes, according to a new estimate from the Centers for Disease Control and Prevention.